Small Interference RNAs (siRNAs)
Researchers from KRIBB Report Details of New Studies and Findings in the Area of Small Interference RNAs (siRNAs)
Published in Gene Therapy Weekly, October 27th, 2011
"Using HFE stably transfected human neuroblastoma cells, we found that cells carrying the C282Y HFE variant do not differentiate when exposed to retinoic acid. Therefore, we hypothesized HFE variants would impact response to therapeutic agents. Both the human neuroblastoma and glioma cells that express the C282Y HFE variant are resistant to Temodar, geldanamycin and gamma-radiation. A gene array analysis...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2011-10-27)
More Articles from Gene Therapy Weekly
- Tissue Engineering
Data on Tissue Engineering Discussed by Researchers at North Shore University Hospital - Biochemistry
Findings from University of Southern California Broaden Understanding of Biochemistry - Adenocarcinomas
New Adenocarcinomas Research from University of Louisville School of Medicine Outlined - Apoptosis
New Apoptosis Study Findings Have Been Reported from University Hospital - Gene Therapy
New Findings in Gene Therapy Described from Catholic University - Gene Therapy
New Gene Therapy Findings from Third Military Medical University Published - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
